Journals / Nöropsikiyatri Arşivi / 2020 / Cilt: 57 - Sayı: 1

Posterior Reversible Encephalopathy Syndrome and Septic Encephalopathy: Neuroimaging, Inflammation and Neurodegeneration Findings

Posterior Reversible Ensefalopati Sendromu ve Septik Ensefalopati: Nörogörüntüleme, İnflamasyon, Nörodejenerasyon Bulguları

Pages
80–82
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We are reporting a patient with septic encephalopathy and PRES with well documented inflammatorybiomarkers and neuroradiological findings

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy syndrome (PRES) is known to be associated with septic encephalopathy.
📊
Key Findings & Data:The pathophysiology of septic encephalopathy is thought to involve inflammatory immune response pathways.
💡
Conclusion & Impact:We are reporting a patient with septic encephalopathy and PRES with well documented inflammatorybiomarkers and neuroradiological findings
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Posterior reversible encephalopathy syndrome (PRES) is known to be associated with septic encephalopathy. The pathophysiology of septic encephalopathy is thought to involve inflammatory immune response pathways. We are reporting a patient with septic encephalopathy and PRES with well documented inflammatorybiomarkers and neuroradiological findings

Özet

Posterior reversible ensefalopati sendromunun (PRES) septik ensefalopati ile ilişkili olduğu bilinmektedir. Septik ensefalopatinin patofizyolojisinin, inflamatuar immün yanıt yolaklarını kapsadığı düşünülmektedir. İnflamatuar biyobelirteçleri ve nöroradyolojik bulguları iyi belgelenmiş olan septik ensefalopatili ve PRES’li bir hastayı rapor ediyoruz.

🔖

Cite This Article

ORHUN, G. (2022). Posterior Reversible Encephalopathy Syndrome and Septic Encephalopathy: Neuroimaging, Inflammation and Neurodegeneration Findings. Nöropsikiyatri Arşivi, Cilt: 57 - Sayı: 1, 80–82. https://ajindex.com/articles/584637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Chen Z, Shen GQ, Lerner A, Gao B. Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome. Brain Res Bull 2017
  2. 93–99. [CrossRef] 2. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015
  3. 914–925. [CrossRef] 3. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006
  4. 2179–2190. Available at: http://www.ajnr.org/ content/27/10/2179.long 4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010
  5. 427–432. [CrossRef] 5. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008
  6. 1036–1042. [CrossRef] 6. Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, Chretien F, Sharshar T. Understanding brain dysfunction in sepsis. Ann Intensive Care 2013
  7. [CrossRef] 7. Esen F, Orhun G, Özcan PE, Brenes Bastos AR, Tüzün E. Diagnosing acute brain dysfunction due to sepsis. Neurol Sci 2019. [CrossRef] 8. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007
  8. 1320–1327. [CrossRef] 9. Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry 2018
  9. 14–20. [CrossRef] 10. Orhun G, Esen F, Özcan PE, Sencer S, Bilgiç B, Ulusoy C, Noyan H, Küçükerden M, Ali A, Barburoğlu M, Tüzün E. Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings. Neurocrit Care 2019
  10. 106–117. [CrossRef] 11. Orhun G, Tüzün E, Özcan PE, Ulusoy C, Yildirim E, Küçükerden M, Gürvit H, Ali A, Esen F. Association Between Inflammatory Markers and Cognitive Outcome in Patients with Acute Brain Dysfunction Due to Sepsis. Noro Psikiyatr Ars 2019
  11. 63–70. [CrossRef] 12. Xu R, Lin F, Bao C, Wang FS. Mechanism of C5a-induced immunologic derangement in sepsis. Cell Mol Immunol 2017
  12. 792–793. [CrossRef] 13. Akrout N, Sharshar T, Annane D. Mechanisms of brain signaling during sepsis. Curr Neuropharmacol 2009
  13. 296–301. [CrossRef] 14. Ward PA. The harmful